Skip to content
OpenCapital
Get started

Zevra Therapeutics, Inc. ZVRA Enterprise value

Enterprise value at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$9.22B-29.3%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$1.83B-51.1%
XER
Xeris Biopharma Holdings, Inc.XERS
$1.15B+8.7%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$684.98M+89.8%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$588.13M+55.1%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$1.61B+304%

Other financials

Income statement

See full
Revenue$36.2M+77.5%
Gross profit$34.3M+80.1%
Operating income$52.1M+1,073%
Net income$37.9M+1,323%
EPS (diluted)$0.60+1,100%

Balance sheet

See full
Cash & equivalents$95.6M+156%
Total debt$1.1M-98.1%
Total equity$205.8M+402%
Total assets$278.6M+61.3%

Cash flow

See full
Operating cash flow$6.1M+175%
CapEx$35.0K-64.6%
Free cash flow$6.1M+173%

Valuation

See full
Market cap$773.23M+56.4%
P/E6.2×—
P/S6.3×-5.9×

Profitability

See full
Gross margin86.1%+7.2pp
Operating margin-103.9%-43.0pp
Net margin101.6%+60.1pp
FCF margin-75%-30.5pp

Returns & leverage

See full
Return on equity100.7%+60.3pp
Debt / equity0×-1.5×
Current ratio4.9×+1.9×

Where this comes from

Calculated from Zevra Therapeutics, Inc.’s reported figures.

$547.2Mmarket cap+$1.1Mtotal debt−$95.6Mcash and equivalents=$452.74M

The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zevra Therapeutics, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zevra Therapeutics, Inc.'s enterprise value?
Zevra Therapeutics, Inc. (ZVRA) reported enterprise value of $452.74M in Q1 2026.
How has Zevra Therapeutics, Inc.'s enterprise value changed year-over-year?
Zevra Therapeutics, Inc.'s enterprise value increased by 5.3% year-over-year, from $429.82M to $452.74M.
What is the long-term trend for Zevra Therapeutics, Inc.'s enterprise value?
Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s enterprise value has grown at a 60.5% compound annual growth rate (CAGR), from $47.46M to $505.23M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.